Complete Mobile Drug Testing Franchise Cost, Revenue & Review 2026
- Investment
- $68K – $288K
- Disclosed sales
- $889K
- gross sales, not profit
- SBA charge-off
- Not SBA-matched
Data from FDD filing
Analysis by FranchiseVerdict Research · Methodology
Complete Mobile Drug Testing is a healthcare services franchise providing mobile drug testing, DNA testing, and background checks. Franchisees run mobile operations, managing testing, collections, and accounts.
FranchiseVerdict summary · 2026
A Complete Mobile Drug Testing franchise requires a total initial investment of $68K – $288K, including a $55K – $215K franchise fee and an ongoing 10.0% royalty[2]. Per the 2026 FDD, average unit revenue was $889K[2]. FranchiseVerdict grade: C (Average), an editorial assessment, not investment advice. Run a live ROI scan →
Limited operating history: franchising since 2025. A system this young has fewer than three years of Item 20 outlet history and rarely enough SBA loans for a charge-off rate, so its grade rests on less evidence than an established system's. Read its Item 20 tables and talk to its first franchisees before relying on the grade. Other new franchisors
Sources, dates and evidence
FDD issued: · Data extracted: · Last cited check: · Staleness risk: low - issued within the last 12 months
Evidence: strong✓ Investment (Item 7)✓ Item 19 status✓ Units and owners (Item 20)✗ SBA loan coverage✓ Litigation (Item 3)✓ Financial statements (Item 21)✓ Franchisor identityhow this is scored7 of 8 headline figures on this page cite a page of the filing; the rest are marked “Not cited” beside the figure.
Overview
- Investment
- $68K – $288K
- 8th pct Healthcare
- Avg gross sales
- $889K
- Company-owned only1 outlet
- Royalty
- 10.0%
- 68th pct Healthcare
- Units
- 1
- 1st pct Healthcare
- SBA charge-off
- N/A
Quick verdict · Healthcare · color = vs category peers
Green = favorable by >10% vs Healthcare median · No shading = within ±10% · Red = unfavorable by >10% · Source: FDD filings + SBA 7(a)
Data from public FDD filings and SBA records. Not financial advice. Methodology
Bottom line
- COSTTotal investment $68K – $288K including a $55K franchise fee, 10.0% ongoing royalty.
- RETURNSAverage unit revenue of $889K/year (median $889K) (company-owned outlets only - not franchisee performance). Estimated payback in 0.5 years.
- RISKVerdict C (Average), verdict score 43/100 (higher is better).
- GROWTHFlat: no net change in franchised outlets in the latest year (0 opened, 0 closed) (Item 20).
- FLAGRevenue data based on only 1 outlet. Treat as directional, not definitive. Ask franchisees directly for current unit economics.
Item 1 · who you're contracting with
The Franchisor
Corporate structure & franchisor financials
- Legal entity
- Complete Mobile Drug Testing Franchise LLC
- Predecessor
- None
- Prior franchisor entity
- CEO title
- Founder and Chief Executive Officer
- Milka Krecak
- Incorporated in
- Wisconsin
- HQ
- 4805 S. 74th St., Suite B, Greenfield, WI 53220
Affiliated brands
- Complete Mobile Drug Testing
Other brands the franchisor or its parent operates (Item 1).
Overview
About
- CEO
- Milka Krecak
- Headquarters
- WI
- Founded
- 2011
- FDD year
- 2026
- States available
- 1
Can you afford it, and what does the money buy?
Entry cost runs 45% below the typical healthcare franchise.
Source: FDD 2026 · Items 5–7
Full Item 7 breakdown15 line items
Initial investment breakdown
| Line item | Low | High | |
|---|---|---|---|
| Initial franchise fee | $55K | $215K | |
| Rent and Deposit | $0 | $6K | |
| Utilities | $0 | $3K | |
| Leasehold Improvements | $0 | $5K | |
| Market Introduction Program | $3K | $5K | |
| Furniture, Fixtures, and Equipment | $0 | $27K | |
| Computer Systems | $3K | $5K | |
| Insurance (3 months) | $800 | $2K | |
| Vehicle | $0 | $4K | |
| Signage | $0 | $500 | |
| Office Expenses | $1K | $3K | |
| Inventory | $700 | $3K | |
| Licenses and Permits | $150 | $250 | |
| Travel, lodging and meals for initial training | $700 | $3K | |
| Additional funds (for first 3 months) | $5K | $8K | |
| Total initial investment | $68K | $288K |
Line items extracted from FDD Item 7. Ranges reflect the franchisor's stated low and high per line. Total is the sum of line-item lows / highs — actual costs may fall outside this range depending on market and build-out scope.
Item 7 · what it costs to open + operate
The Vitals
- Total investment
- $68K – $288K
- Top 40% of category vs category
- Liquid capital req'd
- $5K – $8K
- Top 40% of category vs category
- Franchise fee
- $55K – $215K
- Middle of category vs category
- Royalty
- 10.0%
- typical 6–8%
- Ad fund
- 0.0%
- typical 3–5%
- Total fee load
- 12.0%
- vs 9–13% typical
- Payback period
- 0.5 yrs
- From FDD / Item 19
Ongoing fees · Item 6
| Fee | Amount |
|---|---|
| Royalty | 10.0% of gross sales |
| Marketing / ad fund | 0.0% |
| Technology fee | $250 |
| Training fee | $500 |
| Transfer fee | $15K |
| Renewal fee | $5K |
| Inventory (initial) | $700 – $3K |
| Total fee load | 12.0% of rev |
What do units actually make?
Average unit sales run 32% above the healthcare norm.
Company-owned outlets only - not franchisee performance
Based on a single outlet - not a system average
Source: FDD 2026 · Item 19
Single-unit · not modelled
Returns at a glance
An FDD discloses gross sales, not profit, and the operating costs that turn one into the other are in no filing. We publish no modelled return for Complete Mobile Drug Testing until someone supplies them — yours, in the models below.
—
Not modelled yet
An FDD discloses gross sales, not profit. We hold no sourced figure for COGS, labour, rent / occupancy and other operating costs, and will not substitute an assumed one. Enter your own and the model runs on your assumptions.
Total invested capital · disclosed
$184K
Item 7 initial investment plus working capital, as filed — the one figure here that needs no assumption.
ROI & LBO modelsSingle-unit · 25-unit portfolio · editable
FDD-reported earnings
The FDD reports $394K as Net Profit. This is a disclosed figure, not our estimate — we publish no modelled profit for Complete Mobile Drug Testing.
What one unit earns on your invested capital
Model A · Single-Unit Return
Computes unlevered return on invested capital (ROIC) for a single franchise unit, read against the 30–60% reference band · Yale SOM, Post-MBA Path Exhibit 2 (2023). Below that band a passive index fund likely outperforms; above it the franchisor has pricing power you're subsidizing.
Note: Item 19 revenue is what the franchisor discloses, and it is the top line only — gross sales are not profit. No FDD discloses the operating costs that turn one into the other, so those fields start empty and nothing is modelled until you supply them from your own lease quote, labor market and build-out budget.
Returns model · single-unit ROIC
What would one Complete Mobile Drug Testing unit return on the cash you put in?
Illustrative category typicals — not sourced to any filing, survey or sample. Replace them with figures from franchisee validation calls before you rely on the output.
Unlevered ROIC · per unit
Your modelled return on total invested capital, before any debt financing.
—
An FDD discloses gross sales, not profit. We hold no sourced figure for COGS, labour, rent / occupancy and other operating costs, and will not substitute an assumed one. Enter your own and the model runs on your assumptions.
What 25 units return when you use SBA financing
Model B · Return on Equity: Debt-Financed Acquisition
Models a 25-unit portfolio acquisition financed with an SBA 7(a) loan. Shows equity IRR (your return on cash invested), DSCR (how safely the cash flow covers debt service), and the capital stack (SBA + seller + equity breakdown).
This is the “search fund” or “entrepreneurship through acquisition” scenario: you buy an existing multi-unit operator, use leverage to amplify returns, and either operate or hire management. The 25-unit size is the typical minimum for an SBA-backed franchise portfolio acquisition to pencil as a full-time income.
What “return on equity” means here: if you put in $500K of your own cash and the business generates enough EBITDA to pay down debt and grow, your equity IRR is the annual return on that $500K, including the value created when you eventually sell. Target IRR for a search fund is typically 25–35%.
Not modelled yet
An FDD discloses gross sales, not profit. We hold no sourced figure for COGS, labour, rent / occupancy and other operating costs, and will not substitute an assumed one. Enter your own and the model runs on your assumptions.
A 25-unit return is built on a per-unit EBITDA. Fill in the operating costs in Model A above and this model runs on that figure, or take the whole scenario to the full ROI workbench, where the portfolio and LBO models accept your own per-unit economics directly.
These models are for research and scenario planning only. Not investment advice. Actual results depend on your specific location, management, and market conditions. Consult a franchise attorney and accountant before signing any franchise agreement.
Item 19 · Source: 2026 FDD
Financial Performance
Company-owned outlets only - not franchisee performance
Based on a single outlet - not a system average
- Avg gross sales
- $889K
- Per unit, per year
- Median gross sales
- $889K
- Avg net profit
- $394K
- Reported as Net Profit in FDD Item 19
Gross sales are revenue before expenses — not profit. Actual owner earnings depend on rent, labor, royalties, marketing fees, and debt service.
- Item 19 type
- historic
- Sample size
- 1 outlet
- vs category median 20 · small
- Reported figure
- $889KCited, not corroborated — printed on page 38 of the 2026 FDD. Nothing else in our record independently restates or re-derives it.
- A single outlet — not a range
- Reporting year
- 2025
- Fiscal year the figures cover
- Source filing
- FDD 2026
- Disclosed in the 2026 filing, covering 2025
- Transparency
- 9 / 10
- vs category median 3 / 10 · above
Compared against 162 Healthcare brands
Revenue is 5.0x the investment midpoint. At typical franchise margins, this suggests a payback under 3 years.
Operator outlook
What the numbers say
Data-driven interpretation of this brand's financial disclosures, fee structure, and system trajectory.
Unit economics
Average unit generates $889K/year in gross sales. Revenue-to-investment ratio: 5.0x. Company-owned outlets only - not franchisee performance.
Fee burden
Total ongoing fee load of 12.0% — above the Healthcare median of 8.0%.
Disclosure
Transparency score 9/10 — this franchisor discloses detailed breakdowns (quartiles, segments, or cohort data). Buyers can model unit economics with higher confidence. Sample size of 1 outlet — treat as directional only.
Source: FDD Item 19 financial performance representations and publicly filed FDD data. Past performance is not indicative of future results. Verify all figures with the franchisor and current franchisees before making any investment decision.
vs Healthcare medians
How Complete Mobile Drug Testing Compares
Category median of published Healthcare brands that report the figure; the middle half spans the 25th to 75th percentile and n counts the brands behind it. Medians are used because a few very large systems pull an average far from the typical brand. Revenue is disclosed gross sales, not profit.
Is the system healthy?
Source: FDD 2026 · Item 20
Unit growth
Item 20 · unit dynamics
The Growth Chart
- Total units
- 1
- Opened
- 0
- Last reporting year
- Closed
- 0
- Terminated
- 0
- Franchisor ended the franchise (per Item 20)
- Non-renewed
- 0
- Term expired, not renewed (per Item 20)
- Turnover rate
- N/A
- Company-owned
- 1
- Corporate units in the system
- % franchised
- 0%
- vs corporate-owned
Last fiscal year · Item 20 exits and transfers
- Terminated
- 0
- Not renewed
- 0
- Transferred
- 0
- Reacquired
- 0
- Franchisor bought back
Year-over-year franchised unit counts and net change. Source: FDD Item 20.
Item 12 · 1 state reported
The Territory Map
FDD Item 12 reports the state count, but the specific list isn't in our current data. The map will appear once we re-extract from the FDD or enough franchisee contacts are available.
1
states with franchisees (per FDD Item 12)
SBA loan performance
Government records
SBA Loan Data
Aggregated from SBA 7(a) and 504 loan disclosures, public data unique to FranchiseVerdict.
No SBA loan data available for this brand.
What could kill this investment?
Source: SBA 7(a) FOIA · FDD Items 3, 21
Risk analysis
FranchiseVerdict rating + FDD Items 3, 4, 8, 16, 21
Risk & Legal
Litigation (Item 3)
Subject: officers or affiliates. The franchisor is not a named party in these cases.
No litigation is required to be disclosed in this Item.
Bankruptcy (Item 4)
None disclosed
Audited financials (Item 21)
Yes
Supplier relationship · Items 8 & 16
- Franchisor sells you products: No
- Kickbacks from required suppliers: No
- Must buy proprietary products: No
- Restricted to system-approved products: No
- Can negotiate own supplier terms: No
Score breakdown · what drove the 43 / 100 verdict
- 01MINOROnly 1 unit in system with unknown growth trajectory indicates either brand-new or stagnant franchise
- 02MINOR10% royalty on adjusted gross sales creates ambiguity on what deductions apply before royalty calculation
- 03MINORProtected territory claim unverified with only one franchisee — unclear how franchisor enforces or defines territory boundaries
Severity inferred from the FDD text · not a regulatory classification
What are you signing up for?
Ongoing fees run about 12.0% of sales (royalty + ad fund), before rent and labor.
Source: FDD 2026 · Items 11, 12, 17
FDD Items 12, 15, 17 · continued from Risk & Legal
Contract & Territory Detail
| Initial term | 10 years |
|---|---|
| Renewal term | 5 years |
| Allowed renewalsℹ | 2 |
| Territory type | Exclusive territory |
| Protected territory | Yes |
| Exclusive territoryℹ | Yes |
| Territory population | 250,000 |
| Online sales rights | Restricted |
| Franchisor can compete | Yes |
| Hire a manager? | Allowed |
| Owner-operator | Optional |
| Non-compete (years)ℹ | 2 years |
| Non-compete (miles)ℹ | 5 mi |
| Right of first refusalℹ | Yes |
| RoFR response window | 30 days |
| Transfer requires consent | Yes |
| Termination notice | 30 days |
| Termination groundsℹ | 1 |
| Curable defaultsℹ | 2 |
| Mandatory arbitration | Yes |
| Arbitration location | Greenfield, Wisconsin |
| Jury trial waiver | No |
| Governing law | Wisconsin |
| Litigation count | 0 |
View Item 3 litigation summary
No litigation is required to be disclosed in this Item.
Items 10, 11
Training & Operations
- Classroom training
- 15 hrs
- On-the-job training
- 21 hrs
- Training location
- Greenfield, Wisconsin
- Ongoing training
- Optional
- Time to open
- 4 mo
- From signing to launch
- Site selection
- franchisee
- Franchisor financing
- Not offered
- Item 10
- POS system
- Electronic Merchant Systems
- Operating tech stack
Items 5 & 11
Franchisor Support
Technology: Electronic Merchant Systems
Item 20 · call current owners
Franchisee Contacts
1 owners to call
Name · phone · city · state. Extracted from FDD Item 20
Frequently asked questions
Frequently Asked Questions
How much does it cost to open a Complete Mobile Drug Testing franchise?
The total investment to open a Complete Mobile Drug Testing franchise ranges from $68K – $288K, with an initial franchise fee of $55K. This includes real estate, equipment, inventory, and working capital as disclosed in their Franchise Disclosure Document (FDD).
What do Complete Mobile Drug Testing franchise owners earn?
According to Item 19 of the Complete Mobile Drug Testing FDD, the average gross sales per unit is $889K. The median is $889K. Important context: Company-owned outlets only - not franchisee performance; Based on a single outlet - not a system average. Note: this is gross revenue, not profit. Actual owner earnings vary based on location, operating costs, and management.
Who owns Complete Mobile Drug Testing?
Complete Mobile Drug Testing is franchised by Complete Mobile Drug Testing Franchise LLC. The FDD names no parent company. Source: FDD Item 1, 2026 filing.
What is Item 19 in the Complete Mobile Drug Testing FDD?
The FDD section where a franchisor may disclose financial performance of its outlets. Disclosure is optional and formats vary; figures are typically gross sales, which is revenue before expenses, not profit. FranchiseVerdict extracts these figures directly from the Complete Mobile Drug Testing FDD and qualifies whose outlets they describe.
What is Complete Mobile Drug Testing's franchise failure rate?
SBA 7(a) loan charge-off data is not available for Complete Mobile Drug Testing (fewer than 10 loans on file). Charge-off rates are one way to gauge franchise risk, but not all franchise loans go through the SBA program. We recommend reviewing turnover and closure data in the FDD and speaking with current franchisees.
How many Complete Mobile Drug Testing franchise locations are there?
As of their most recent FDD filing, Complete Mobile Drug Testing has 1 total units in the United States.
Is Complete Mobile Drug Testing a good franchise to buy?
FranchiseVerdict rates Complete Mobile Drug Testing as a C-grade franchise with a verdict score of 43 out of 100 (higher is better). The grade is a deterministic score built from six weighted dimensions — financial health, unit economics, unit growth, scale, legal, and transparency — then calibrated against SBA loan charge-off rates and FDD age. Transparency is one of the six, so a filing that discloses less scores lower on that dimension than one that discloses more. Our rating is based solely on publicly available FDD and government data; we recommend speaking with current franchisees before making any investment decision. This is not investment advice.
Data sourced from public FDD filings and SBA 7(a) FOIA records. Not financial advice.
For franchisors
Are you the franchisor?
If you represent Complete Mobile Drug Testing, you can request corrections or provide updated information.
Other Healthcare franchises
Compare similar franchise opportunities in the Healthcare category
Data extracted from public FDD filings and SBA 7(a) loan disclosures (FOIA). This information is provided for research purposes only and does not constitute financial, legal, or investment advice. Verify all figures with the franchisor's current Franchise Disclosure Document before making any investment decision.